Stocks & Investing
Stocks and Investing
Stocks and Investing
Wed, March 30, 2022
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
[ Wed, Mar 30th 2022
] - WOPRAI
Tue, March 29, 2022
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
[ Tue, Mar 29th 2022
] - WOPRAI
Nathan Weinstein Initiated (TRVI) at Strong Buy and Held Target at $10 on, Mar 29th, 2022
Nathan Weinstein of Aegis Capital, Initiated "Trevi Therapeutics, Inc." (TRVI) at Strong Buy and Held Target at $10 on, Mar 29th, 2022.
Nathan, nor any peers, have made any analyst calls on TRVI in the last 4 months.
Warning: Undefined array key "user_peer_history" in /tmp/a6c06072cf4de09d3b84c924bfa9ab126ebc2b66_0.file.analysis.tpl.php on line 30